LeonaBio, Inc. (LONA)Healthcare | Biotechnology | Bothell, United States | NasdaqCM
7.94 USD
+0.05
(0.634%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.83 -0.11 (-0.110%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:43 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish as the stock trades near its 50-day average, showing no clear momentum breakout despite a recent bounce off oversold levels. However, the long-term investment case is severely compromised by a catastrophic multi-year decline; the asset has lost over 96% of its value since 2021, with the most recent annual performance being a devastating -87% drop. This trajectory indicates a fundamental breakdown rather than a temporary correction, rendering the current low valuation a reflection of deteriorating business quality rather than a margin of safety. Furthermore, the company operates in the biotechnology sector with no history of paying dividends, offering no income floor to offset the massive capital loss risks inherent in such a distressed equity. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.092678 |
| AutoETS | 0.106036 |
| AutoARIMA | 0.107102 |
| MSTL | 0.108652 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 1.02 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.244 |
| Excess Kurtosis | -0.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.718 |
| Market Cap | 74,808,008 |
| Beta | 2.04 |
| Previous Name | Athira Pharma, Inc. |
| Website | https://www.leonabio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0387597 |
| Address1 | 18,706 North Creek Parkway |
| Address2 | Suite 104 |
| All Time High | 347.9 |
| All Time Low | 2.2 |
| Ask | 8.12 |
| Ask Size | 1 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 88,590 |
| Average Daily Volume3 Month | 35,462 |
| Average Volume | 35,462 |
| Average Volume10Days | 88,590 |
| Beta | 2.041 |
| Bid | 7.17 |
| Bid Size | 1 |
| Board Risk | 6 |
| Book Value | 3.566 |
| City | Bothell |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.94 |
| Current Ratio | 7.011 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 8.0 |
| Day Low | 7.94 |
| Debt To Equity | 1.718 |
| Display Name | LeonaBio |
| Earnings Timestamp End | 1,786,046,400 |
| Earnings Timestamp Start | 1,786,046,400 |
| Ebitda | -53,828,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.452 |
| Enterprise Value | 24,318,004 |
| Eps Trailing Twelve Months | -23.16 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.081 |
| Fifty Day Average Change | -0.14100027 |
| Fifty Day Average Change Percent | -0.017448368 |
| Fifty Two Week Change Percent | 103.87597 |
| Fifty Two Week High | 14.21 |
| Fifty Two Week High Change | -6.27 |
| Fifty Two Week High Change Percent | -0.44123855 |
| Fifty Two Week Low | 3.53 |
| Fifty Two Week Low Change | 4.41 |
| Fifty Two Week Low Change Percent | 1.2492918 |
| Fifty Two Week Range | 3.53 - 14.21 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,600,435,800,000 |
| Float Shares | 4,730,429 |
| Free Cashflow | -23,139,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 19 |
| Fullday Change | 0.0500002 |
| Fullday Change Percent | 0.633716 |
| Fullday Price | 7.83 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04493 |
| Held Percent Institutions | 0.87662005 |
| Implied Shares Outstanding | 9,421,663 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,758,153,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer's disease and Parkinson's disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington. |
| Long Name | LeonaBio, Inc. |
| Market | us_market |
| Market Cap | 74,808,008 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_266015004 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -141,455,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 74,336,921 |
| Number Of Analyst Opinions | 3 |
| Open | 8.0 |
| Operating Cashflow | -61,926,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 425 620 8501 |
| Post Market Change | -0.11000013 |
| Post Market Change Percent | -1.3853921 |
| Post Market Price | 7.83 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Athira Pharma, Inc. |
| Previous Close | 7.89 |
| Price Hint | 2 |
| Price To Book | 2.2265844 |
| Profit Margins | 0.0 |
| Quick Ratio | 6.533 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.05000019 |
| Regular Market Change Percent | 0.633716 |
| Regular Market Day High | 8.0 |
| Regular Market Day Low | 7.94 |
| Regular Market Day Range | 7.94 - 8.0 |
| Regular Market Open | 8.0 |
| Regular Market Previous Close | 7.89 |
| Regular Market Price | 7.94 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 5,034 |
| Return On Assets | -0.74065 |
| Return On Equity | -4.3139 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 9,421,663 |
| Shares Percent Shares Out | 0.0041 |
| Shares Short | 38,973 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 53,976 |
| Short Name | LeonaBio, Inc. |
| Short Percent Of Float | 0.0053 |
| Short Ratio | 2.36 |
| Source Interval | 15 |
| State | WA |
| Symbol | LONA |
| Target High Price | 20.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 17.33333 |
| Target Median Price | 17.0 |
| Total Cash | 51,067,000 |
| Total Cash Per Share | 5.42 |
| Total Debt | 577,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -23.16 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.4049 |
| Two Hundred Day Average Change | 0.5351 |
| Two Hundred Day Average Change Percent | 0.07226296 |
| Type Disp | Equity |
| Volume | 5,034 |
| Website | https://www.leonabio.com |
| Zip | 98,011 |